12:30 p.m. - 2:00 p.m. PT
  Session: Surface modifications and coatings
  Co-Chairs: Lijun Zou, W.L. Gore & Associates, Inc. and Kris Lavery, Verily Life Sciences

  12:30 p.m.

Yi Chen, Nanoengineering, University of California-San Diego
"Clathrin patch mimicking through DNA self-assembly"

  1:10 p.m.

Bob Hergenrother, Biocoat, Inc.
"Effect of sterilization on hydrophillic coatings"

  1:35 p.m.

Kevin Chen, Medical Surface Inc.
"A multifaceted approach to develop and optimize surface coatings for diverse medical devices"

  10:30 a.m.

David Vachon, Iasis Molecular Sciences
"In vitro and in vivo evaluations of novel antimicrobial composites for aiding healing and preventing the colonization of urological devices"

  11:05 a.m.

Emma Garcia, IsurTec, Inc.
"Electrospinning novel biointerfaces to enhance tissue integration for musculoskeletal and neurological applications"

  11:35 a.m.

Chandru RamaSubramaniam, Medtronic Inc.
"Design considerations for the development of radiopaque medical devices"

Robert Langer
Robert Langer is one of 12 Institute Professors at the Massachusetts Institute of Technology (MIT)

"Biomaterials and biotechnology:  From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering."

   12:00 p.m.

Daniel Siegwart, Department of Biochemistry at UT Southwestern Medical Center
"Selective ORgan Targeting (SORT): A strategy for effective tissue specific mRNA delivery and CRISPR/Cas gene editing"

   12:25 p.m.

Yizhou Dong, College of Pharmacy, The Ohio State University
"Development of nanomaterials for mRNA therapeutics, genome editing and cell therapy"

   12:55 p.m.

Gaurav Sahay, College of Pharmacy, Oregon State University
"Rapid in-vivo generation of decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2"

   10:00 a.m. - 11:00 a.m. PT
   Keynote Speaker - Bob Ward, President and CEO of Exthera Medical

"A therapeutic device for treating COVID-19: The role of surface science."

   11:00 a.m. - 12:30 p.m. PT
   Session: Tissue engineering and regenerative medicine
   Co-Chairs: Rob Diller, Amnio Technology and Chander Chawla, DSM Biomedical Inc.

  11:00 a.m.

Elizabeth Cosgriff-Hernandez, The University of Texas at Austin
"Engineered matrices to improve bone regeneration with the Masquelet technique"

  11:35 a.m.

Joachim Kohn, Department of Chemistry and Chemical Biology, Rutgers University
"Materiobiology: An emerging field of research"

12:05 p.m.

Lumei Liu, The Abigail Wexner Research Institute at Nationwide Children's Hospital
"Modulation of tissue-engineered tracheal grafts using composite extracellular matrix-polymer scaffolds"

Wednesday, October 28, 2020

   10:30 a.m. - 12:00 p.m.PT
   Session: Analytical tools
   Co-Chairs: Aaron Cassely, EAG, Mourad Rahi, American Preclinical Services and Joshua Schmidt, SenzaGen, Inc.

   10:30 a.m.

Ted Heise, MED Institute
"ISO 10993-18; Implementing chemical characterization in support of the biological evaluation of medical devices"

   11:05 a.m.

Joshua Schmidt, SenzaGen, Inc.
"Leveraging in vitro to forecast in vivo success"

   11:35 a.m.

Mourad Rahi, American Preclinical Services
"Extractable & leachables and particulates analysis: importance of sample preparation, data collaboration and interpretation"